![Serge Sagodira](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Serge Sagodira
Sociétés | Poste | Début | Fin |
---|---|---|---|
DeuterOncology SA
![]() DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - |
Historique de carrière de Serge Sagodira
Statistiques
Internationale
Belgique | 2 |
Opérationnelle
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
DeuterOncology SA
![]() DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Health Technology |
- Bourse
- Insiders
- Serge Sagodira
- Expérience